1160.63.43002 Boehringer Ingelheim Investigational Site

Vienna

0 studies enrolling now · 1 studies all time

What they study most

Venous Thromboembolism

Studies at this site

• Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE — Completed